Current through Register No. 40, October 3, 2024
(a) In accordance
with RSA
141-B:7, all facilities shall report
diagnosis or treatment of a reportable cancer to the SCR in accordance with the
rules specified below, and using the means described in
He-P
304.02(f), (g) and (h) . SCR may be
contacted through http://geiselmed.dartmouth.edu/nhscr/contact.
(b) Pursuant to (a) above, all facilities
shall include information and data in each report describing cancer diagnosis
or treatment according to one of the following standards, as applicable:
(1) The North American Association of Central
Cancer Registries (NAACCR), "Standards for Cancer Registries, Volume II/Data
Standards and Data Dictionary, 19th Edition, Record Layout Version 15,"
(January 1, 2015) Edited by Monica Thornton, Revised (February, 27, 2015.), as
listed in Appendix A and available as a free document at
www.naaccr.org;
(2) The North American Association of Central
Cancer Registries (NAACCR), "Standards for Cancer Registries/Volume V:
"Pathology Laboratory Electronic Reporting, Version 4.0." Klein Wt., Havener L
(eds.), Springfield (IL); North American Association of Central Cancer
Registries, Inc., April, 2011, as listed in Appendix A and available as a free
electronic document at
www.naaccr.org;
or
(3) The National Center for
Chronic Disease Prevention and Health Promotion Division of Cancer Prevention
and Control, "Implementation Guide for Ambulatory Healthcare Provider Reporting
to Central Cancer Registries HL7 Clinical Document Architecture (CDA) Release
1.1" (March, 2014), as listed in Appendix A and available as a free electronic
document in PDF format at
http://cdc.gov/cancer/npcr/ehrmeaningfuluse/cancer.htm.
(c) Each report shall contain
information or data required by the appropriate standard in (b) above, as
listed in elements (1) -(10) below, and include any supporting information, as
follows:
(1) Item numbers defining
demographics;
(2) Item numbers
defining cancer identification;
(3)
Item numbers defining hospital-specific information;
(4) Item numbers defining stage prognostic
factors;
(5) Item numbers defining
the first course of treatment;
(6)
Item numbers defining follow-up, recurrence, and death;
(7) Item numbers defining confidential
patient information;
(8) Item
numbers defining confidential hospital information;
(9) Item numbers defining other confidential
information; and
(10) Item numbers
defining diagnosis.
(d)
Of the item numbers specified in (b) and (c) above, the following shall require
rapid reporting as defined in
He-P
304.01(l) and described in
He-P
304.03(b) and (c) :
(1) Item numbers defining
demographics;
(2) Item numbers
defining cancer identification;
(3)
Item numbers defining hospital-specific information;
(4) Item numbers defining confidential
patient information; and
(5) Item
numbers defining other confidential information.
(e) The items listed in (c) above shall
require definitive reporting as defined in
He-P
304.01(e) , and described in
He-P
304.03(a) ,
He-P
304.03(d) ,
He-P
304.04(a) , and
He-P
304.06(a) and (b) .
(f) All facilities making an electronic
report to the SCR in accordance with (a) above, shall submit through a secure
internet-based encrypted mechanism, such as a direct file transfer, or a
web-based reporting form supported by the SCR.
(g) All facilities reporting electronically
shall format reports as specified by one of the following standards, as
applicable:
(1) The North American
Association of Central Cancer Registries (NAACCR), "Standards for Cancer
Registries, Volume II/Data Standards and Data Dictionary, 19th Edition, Record
Layout Version 15." (January 1, 2015) Edited by Monica Thornton, Revised
(February, 27, 2015), as listed in Appendix A and available as a free document
at
http://www.naaccr.org;
(2) The North American Association of Central
Cancer Registries (NAACCR), "Standards for Cancer Registries/Volume V:
Pathology Laboratory Electronic Reporting, Version 4.0." Klein Wt., Havener L.
(eds.) Springfield (IL); North American Association of Central Cancer
Registries, Inc., (April, 2011), as listed in Appendix a and available as a
free electronic document at
http://www.naaccr.org; or
(3) The National Center for Chronic Disease
Prevention and Health Promotion Division of Cancer Prevention and Control,
"Implementation Guide for Ambulatory Healthcare Provider Reporting to Central
Cancer Registries HL7 Clinical Document Architecture (CDA) Release 1.1" (March,
2014), as listed in Appendix A and available as a free electronic document in
PDF format at
http://cdc.gov/cancer/npcr/ehrmeaningfuluse/cancer.htm.
(h) Where electronic reporting is
not feasible, facilities shall complete and file the New Hampshire State Cancer
Registry (NHSCR) "Cancer Report Form" (July, 2015) provided by the SCR and
faxed or mailed by the facilities to the SCR, via regular mail or a courier
service.
#4055, eff 5-27-86, EXPIRED: 5-27-92
New. #5601, eff 3-24-93; amd by
#6075, eff 8-5-95; ss by #7406, eff 11-21-00; ss by #9046, eff
12-5-07
